KRAS and neoplasm: A therapeutic study of mRNA similarly encoding multiple KRAS variants increased tumor-infiltration of CD8+ T cells and significantly delayed tumor growth in the syngeneic KRAS G12C-expressing lung cancer LL/2-bearing mice [73].